ARROGENE, INC 3
3 · ARROGENE, INC · Filed May 23, 2016
Insider Transaction Report
Form 3
SNUKAL ROBERT MARTIN
Director
Holdings
Convertible Note
Exercise: $750000.00From: 2016-04-30Exp: 2021-04-30→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]Conversion Price shall be the lesser of (i) $1.00 per share or (ii) if the Company has completed a Qualified Financing (as that term is defined in the Convertible Note) prior to the Conversion Date, the price per share of Common Stock Equivalent in the Qualified Financing. The number of shares reflected in this Report assume a conversion price of $1.00 per share.